Abstract
We have previously shown that RB plays an important role in the maintenance of the epithelial phenotype. p21 is also involved in several terminal differentiation systems including keratinocytes. We report here that p21 is an RB target gene in epithelial cells, but not in fibroblasts where RB is unable to transactivate p21 transcriptional expression. In epithelial cells, when RB family factors were inactivated by SV40 T antigen (LT), p21 expression was strongly repressed, whereas its expression was not affected when the cells were transformed by a mutated LT leaving RB active but inactivating p53. Moreover, retransformation by RB of LT transformed epithelial cells totally restored p21 expression. By cotransfection experiments and using deletions and point mutations of the p21 promoter, we show that the minimal region required for the RB-mediated transcriptional activation maps to a GC-rich region located between −83 and −74. This region is shown to interact specifically with the transcription factor Sp1 and Sp3. Thus for the first time, we show a positive transcriptional relationship between RB and p21 in epithelial cells. Since p21 keeps RB in a hypophosphorylated state important for its transcriptional activity during differentiation, our results imply an auto-loop of regulation between RB and p21 that may be essential for the maintenance of the differentiation state. We propose that this transcriptional relationship might be necessary of their roles in cell cycle arrest and in several differentiation pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Batsché E, Muchardt C, Behrens J, Hurst HC and Cremisi C. . 1998 Mol. Cell. Biol. 18: 3647–3658.
Behrens J, Lowrick O, Klein-Hitpass L and Birchmeier W. . 1991 Proc. Natl. Acad. Sci. USA 88: 11495–11499.
Biggs JR, Kudlow JE and Kraft AS. . 1996 J. Biol. Chem. 271: 901–906.
Billon N, Carlisi D, Datto MB, Van Grunsven LA, Watt A, Wang XF and Rudkin BB. . 1999 Oncogene 18: 2872–2882.
Chen LI, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K, Fu YH, Grunwald S and Chiu R. . 1994 Mol. Cell. Biol. 14: 4380–4389.
Chen PL, Riley DJ, Chen Y and Lee WH. . 1996a Genes Dev. 10: 2794–2804.
Chen PL, Riley DJ, Chen-Kiang S and Lee WH. . 1996b Proc. Natl. Acad. Sci. USA 93: 465–469.
Datto MB, Yu Y and Wang XF. . 1995 J. Biol. Chem. 270: 28623–28628.
Dignam JD, Lebovitz RM and Roeder RG. . 1983 Nucleic Acids Res. 11: 1475–1489.
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
El-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. . 1995 Cancer Res. 55: 2910–2919.
Fuchs E. . 1993 J. Cell. Sci. (Suppl.) 17: 197–208.
Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lassar AB. . 1995 Science 267: 1018–1021.
Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.
Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fischer PB. . 1994 Oncogene 9: 3397–3406.
Kim SJ, Lee HD, Robbins PD, Busam K, Sporn MB and Roberts AB. . 1991 Proc. Natl. Acad. Sci. USA 88: 3052–3056.
Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR and Robbins PD. . 1992 Mol. Cell. Biol. 12: 2455–2463.
Kivinen L, Tsubari M, Haapajarvi T, Datto MB, Wang XF and Laiho M. . 1999 Oncogene 18: 6252–6261.
Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N, Rogan EM, Reddel R and Harris C. . 1993 Carcinogenesis 14: 833–839.
Li CY, Suardet L and Little JB. . 1995 J. Biol. Chem. 270: 4971–4974.
Lipinski MM and Jacks T. . 1999 Oncogene 18: 7873–7882.
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. . 1995 Genes Dev. 9: 935–944.
Martel C, Batsché E, Harper F and Cremisi C. . 1996 Cell. Death Diff. 3: 285–298.
Martel C, Harper F, Cereghini S, Noe V, Mareel M and Cremisi C. . 1997 Cell Growth Differ. 8: 165–178.
Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM and Dotto GP. . 1995 Proc. Natl. Acad. Sci. USA 92: 5451–5455.
Nead MA, Laurel AB, Antinore MJ, Ludlow JW and McCance DJ. . 1998 EMBO J. 17: 2342–2352.
Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR. . 1994 Exp. Cell. Res. 211: 90–98.
Owen GI, Richer JK, Tung L, Takimoto G and Horwitz KB. . (1998) J. Biol. Chem. 273: 10696–10701.
Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ. . 1995 Science 267: 1024–1027.
Prowse DM, Bolgan L, Molnar A and Dotto GP. . 1997 J. Biol. Chem. 272: 1308–1314.
Robbins PD, Horowitz JM and Mulligan RC. . 1990 Nature 346: 668–671.
Saffer JD, Jackson SP and Annarella MB. . 1991 Mol. Cell. Biol. 11: 2189–2199.
Sezkely L, Jiang W, Buclic-Jakus F, Rosen A, Ringertz N, Klein G and Winam KG. . 1992 Cell Growth Differ. 3: 149–156.
Shao Z, Ruppert S and Robbins PD. . 1995 Proc. Natl. Acad. Sci. USA 92: 3115–3119.
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL and El-Deiry WS. . 1997 Nature 389: 187–190.
Suzuki T, Kimura A, Nagai R and Horikoshi M. . 2000 Genes Cells 5: 29–41.
Udvadia AJ, Rogers KT, Higgins PD, Murata Y, Martin KH, Humphrey PA and Horowitz JM. . 1993 Proc. Natl. Acad. Sci. USA 90: 3265–3269.
Udvadia AJ, Templeton DJ and Horowitz JM. . 1995 Proc. Natl. Acad. Sci. USA 92: 3953–3957.
Wang JY, Knudsen ES and Welch PJ. . 1994 Adv. Cancer Res. 64: 25–85.
Weinberg RA. . 1995 Cell 81: 323–330.
Xiong Y, Hannon GJ, Zhang H, Carso D, Kobayashi R and Beach D. . 1993 Nature 366: 701–704.
Yan GZ and Ziff EB. . 1997 J. Neurosci. 17: 6122–6132.
Zeng YX, Somasundaram K and el-Deiry WS. . 1997 Nat. Genet. 15: 78–82.
Acknowledgements
We are very grateful to Dr WS El-Deiry for the generous gift of p21 constructs. We wish to thank Drs M Ernoult, H Lehrmann and T Magnaldo for helpful discussions and Drs S Timmermann, M Ernoult and T Magnaldo and for critical reading of the manuscript. This work was supported by grants from ARC (N° 9979), the GEFLUC and the Fondation pour la recherche medicale. JT Decesse was supported by predoctoral fellowships from the Ministère de la Recherche.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Decesse, J., Medjkane, S., Datto, M. et al. RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 20, 962–971 (2001). https://doi.org/10.1038/sj.onc.1204169
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204169
Keywords
This article is cited by
-
Lifestyle chemical carcinogens associated with mutations in cell cycle regulatory genes increases the susceptibility to gastric cancer risk
Environmental Science and Pollution Research (2018)
-
Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors
Cell Death & Disease (2013)
-
Retinoblastoma protein acts as Pax 8 transcriptional coactivator
Oncogene (2005)
-
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer
Nature Clinical Practice Urology (2005)
-
Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence
Oncogene (2003)